Sleep Disorders News

Among patients with obstructive sleep apnea, receipt of sulthiame for 15 weeks reduced breathing pauses during sleep and daytime sleepiness, according to an abstract presented at the European Respiratory Society International Congress.

For infants with Down syndrome, early intervention to address obstructive sleep apnea may lead to better cognitive and behavioral outcomes at 36 months, according to new research from The Lancet.

The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.

Currently, cognitive behavioral therapy for insomnia is the gold standard treatment for sleep disturbances associated with menopause, and research is underway to better target neurons responsible for sleep disturbances.

Among adults with obstructive sleep apnea, excessive daytime sleepiness decreased with 1 year of pitolisant treatment, according to results published in CHEST.

PHILADELPHIA — In a small cohort of individuals with mild cognitive impairment or dementia, sleep disruption was associated with weekly agitation level, according to a presenter.

PHILADELPHIA — Longer sleep duration may be linked to neurodegeneration as a likely risk factor for future cognitive decline and dementia, with depression also influencing sleep and cognitive deficit, according to a poster presentation.

PHILADELPHIA — In cognitively healthy but sleep-poor adults in midlife, treatment with 20 mg suvorexin led to acute decreases in Alzheimer’s-related biomarkers compared with 10 mg of the drug and placebo, according to a presenter.

Is there such a thing as having a broken heart from depression?